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Aims:  To determine  the  degree  to which  cigarette  smoking  predicts  levels  of cannabis  dependence  above
and  beyond  cannabis  use  itself, concurrently  and in  an  exploratory  four-year  follow-up,  and  to  investigate
whether  cigarette  smoking  mediates  the  relationship  between  cannabis  use  and  cannabis  dependence.
Methods:  The  study  was  cross  sectional  with  an exploratory  follow-up  in  the  participants’  own  homes  or
via telephone  interviews  in  the  United  Kingdom.  Participants  were  298  cannabis  and  tobacco  users  aged
between  16 and  23;  follow-up  consisted  of  65  cannabis  and  tobacco  users.  The  primary  outcome  variable
was  cannabis  dependence  as  measured  by the  Severity  of  Dependence  Scale  (SDS).  Cannabis  and  tobacco
smoking  were  assessed  through  a self-reported  drug  history.
Results:  Regression  analyses  at baseline  showed  cigarette  smoking  (frequency  of cigarette  smoking:
B  =  0.029,  95%  CI  = 0.01,  0.05;  years  of cigarette  smoking:  B =  0.159,  95% CI = 0.05,  0.27)  accounted  for  29%
of  the  variance  in  cannabis  dependence  when  controlling  for frequency  of cannabis  use.  At  follow-up,
only  baseline  cannabis  dependence  predicted  follow-up  cannabis  dependence  (B = 0.274,  95%  CI  = 0.05,
0.53).  At  baseline,  cigarette  smoking  mediated  the  relationship  between  frequency  of  cannabis  use  and
dependence  (B = 0.0168,  95%  CI  = 0.008,  0.288)  even  when  controlling  for  possible  confounding  variables
(B  =  0.0153,  95% CI  =  0.007,  0.027).
Conclusions:  Cigarette  smoking  is related  to concurrent  cannabis  dependence  independently  of  cannabis
use frequency.  Cigarette  smoking  also  mediates  the  relationship  between  cannabis  use  and  cannabis
dependence  suggesting  tobacco  is a partial  driver  of  cannabis  dependence  in young  people  who  use
cannabis  and  tobacco.
ublis©  2015  The  Authors.  P
. Introduction
Together, cannabis and tobacco are two of the world’s most used
rugs, and despite their unique smoking relationship, relatively lit-
le is known about their combined effects. The high prevalence of
annabis use amongst young people in the UK is a growing concern.
owever, many daily cannabis users do not develop dependence.
rospective studies of the likelihood of developing a Cannabis
se Disorder (CUD) have investigated predictors of dependence
mongst cannabis users (Swift et al., 2000; van der Pol et al., 2013)
ith baseline severity of dependence acting as a main predictor
f dependence at one-year follow-up (Swift et al., 2000). How-
ver, there are a host of other factors which have been considered
∗ Corresponding author. Tel.: +44 02031083319.
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license  (http://creativecommons.org/licenses/by/4.0/).
predictors of developing a CUD, for example; age of onset (Chen
et al., 2005), gender (Coffey et al., 2000; von Sydow et al., 2002),
impulsivity (Swift et al., 2008), mental health problems (Wittchen
et al., 2007) and early onset of continued tobacco smoking (Coffey
et al., 2000; Prince van Leeuwen et al., 2014; von Sydow et al., 2002).
More recently, van der Pol et al. (2013) investigated a population of
high risk young adult cannabis users and found that recent nega-
tive life events and social support factors such as living alone were
more predictive of CUD then cannabis exposure variables suggest-
ing the existing literature on the aetiology of cannabis use disorder
is limited.
Relatively, tobacco is more harmful than cannabis (Nutt et al.,
2010) and the majority of tobacco smokers are indeed nicotine
dependent. The gateway hypothesis posits that tobacco acts as a
gateway drug to the use of cannabis (Kandel et al., 1992). However,
there is strong evidence for the ‘reverse gateway’ whereby cannabis
smoking predicts tobacco onset (Patton et al., 2005). Several lines of
article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Identi fied through ba seli ne 
databas e that con sen ted  and 
provided detail s for futur e 
contact (n= 34 1)
Excluded (n= 234): 
- In correct  contact  details  (n = 88) 
- Decli ned  to partici pate  (n= 10) 
- Agree d to parti cipate bu t could 
not be  contac ted  (n = 16) 
- Never repli ed (n=  117) 
- Other (n= 3) 
Successfully  contacted  and 
inter viewed  (n=  107) Excluded (n=  42) : 
- Not re gular tobac co users at 
baseli ne (n= 24) 
- Not re gular cann abis us ers  at 
baseli ne (n= 3)  
- Data miss ing  (n =15) Analy sed (n= 65) 66 C. Hindocha et al. / Drug and Alc
nvestigation give weight to the hypothesised association between
annabis use and tobacco smoking. Firstly, there is evidence to sug-
est both nicotine and cannabis affect similar mesolimbic dopamin-
rgic pathways suggesting overlapping mechanism in addiction
David et al., 2005; Filbey et al., 2009). Secondly, there are shared
enetic (Agrawal et al., 2008, 2010), temperamental (Brook et al.,
010; Creemers et al., 2009) and psychological factors (Brook et al.,
010) that have been associated with the use of both drugs. Finally,
oth substances are smoked and often concurrently, such that
ross-sensitisation to each substance might occur, with tobacco
irectly enhancing the subjective effect of cannabis (Agrawal and
ynskey, 2009; Baggio et al., 2013; Ream et al., 2008). As nicotine is
ore addictive than cannabis, tobacco smoking may be a primary
river of continued use and relapse in co-dependent users.
About 90% of cannabis users also identify as cigarette smokers
Agrawal et al., 2012), however, this exists as a complicated rela-
ionship given that increased cigarette smoking may  substitute for
educed cannabis consumption (Allsop et al., 2014) and vice versa.
sers of both drugs report more severe symptoms of CUD (Peters
t al., 2012). Half of adults seeking treatment for CUD also smoke
igarettes and treatment outcomes for those using both cannabis
nd tobacco, in comparison to cannabis alone, are poor (Agrawal
t al., 2009). Moreover, relative to those with a CUD, those with
o-occurring nicotine dependence show poorer psychiatric and
sychosocial outcomes (Peters et al., 2014; Ramo et al., 2013). In
 recent controlled laboratory study, Haney et al. (2012) found that
he strongest predictor of relapse in cannabis dependent individ-
als was their cigarette smoking status. Further, cigarette smoking
d libitum or after a short period of abstinence were both associated
ith relapse to cannabis use thus ruling out acute nicotine expo-
ure or conditioned motivation (i.e., transfer) effects. This study
uggests that cigarette smoking alongside cannabis use may  confer
 greater dependence syndrome and therefore a greater likelihood
o relapse.
To understand the factors involved in the maintenance of sub-
tance use, such that prevention strategies are better informed,
ongitudinal designs of the use of both drugs are essential, espe-
ially during the critical period of adolescence. The present study
imed to investigate the degree to which cigarette smoking predicts
he level of cannabis dependence above and beyond cannabis use
tself, both at baseline, and in an exploratory four-year follow-up in
 sample of young cannabis and tobacco users. Cigarette smoking
t baseline, independently of smoking cannabis, is hypothesised
o contribute to CUD concurrently and at follow up. Moreover,
ollowing previous research (Haney et al., 2012) we  aimed to
nvestigate if the effects of cannabis use on cannabis depend-
nce are mediated by tobacco smoking using a multiple mediator
odel.
. Methods
.1. Design and participants
.1.1. Baseline. A sample of 298 cannabis users who  also used tobacco (≥1
ay/month) were selected from a sample comprising of over 400 recreational (1–24
ays/month) and daily (≥25 days/month) users aged 16–23 years old, as described
lsewhere (Freeman et al., 2014; Morgan et al., 2012). Inclusion criteria were (a) to
peak English ﬂuently, (b) not to have learning impairments, (c) to have no history
f psychotic illnesses and (d) normal or corrected-to-normal vision. All participants
rovided written, informed consent. Participants could also consent to be contacted
or further studies and provided contact details as such. The study was  approved by
he  UCL Ethics Committee and its aims were supported by the UK Home Ofﬁce.
.1.2. Procedure. Baseline measures were collected in participants’ homes as part
f  a larger study investigating acute cannabis effects. Participants were required to
bstain from all recreational drugs including alcohol for 24 h before each test day.
emographic information, a drug history and assessment of CUD, via the Severity
f  Dependence Scale (SDS; Gossop et al., 1995), were completed while participants
ere abstinent. Participants’ past use of cannabis and tobacco were assessed using
 semi-structured, questionnaire-based interview which included the followingFig. 1. Participant ﬂow diagram for opportunistic follow up, 4 years after baseline.
questions: (a) when did you last use tobacco? (b) For how many years have you
smoked tobacco? (YEARS-TOB) (c) In a typical month, how many days do you use
tobacco? (DAYS-TOB) (d) How many cigarettes do you smoke per day? (e) When
did  you last use cannabis? (f) For how many years have you used cannabis? (g) In
a  typical month, how many days do you use cannabis? (DAYS-CANNABIS) (h) How
long does it take you to smoke an eighth (3.5 g)?
Participants were assessed for cannabis dependence using the SDS which is
ﬁve-item questionnaire focusing on ‘loss of control’ or ‘psychological dependence’
in  relation to cannabis use. It has good and well-established psychometric prop-
erties and was found to be of equal utility in diagnosing cannabis dependence in
comparison to more formal diagnostic assessments (Swift et al., 1998). A score
of  three on the SDS indicates cannabis dependence (Swift et al., 1998). The fol-
lowing measures were also administered; (a) the Wechsler Test of Adult Reading
(WTAR; Wechsler, 2001) which is a measure of premorbid verbal intelligence (IQ)
and consists of 50 irregularly spelt words. Scores range from 0 to 50; (b) the Schizo-
typal Personality Questionnaire (SPQ; Raine, 1991) which is a 74-item questionnaire
where higher scores indicate a greater schizotypal personality disorder severity; (c)
the State-Trait Anxiety Inventory (STAI; Spielberger, 1983), only the 20 items from
the  trait scale were administered with higher scores reﬂecting greater trait anxiety;
(d) the Barratt Impulsiveness Scale (BIS-11; Patton et al., 1995) which is a 30 item
questionnaire describing common impulsive behaviours, high scores reﬂect greater
impulsivity; (e) the Beck Depression Inventory (BDI; Beck et al., 1961) which is a 21
item questionnaire indexing depression over the past week (a score of 10 indicates
mild depression) and (f) the Childhood Trauma Questionnaire (CTQ; Bernstein et al.,
2003) which is a 28 item questionnaire assessing history of abuse.
2.2. Follow up
At follow-up, four years later, we attempted to re-contact the 341 participants
who  gave consent and invited them to participate in a semi-structured telephone
interview (see Fig. 1 for participant ﬂow diagram). The ﬁnal sample consisted of 65
cannabis and tobacco smokers.
Participants were recruited through a preliminary email requesting their partic-
ipation. All participants gave informed consent by telephone and were entered into
a  prize draw to win  a tablet computer for participating. Telephone interviews were
conducted between October and December 2013. Demographics, a drug history and
the  SDS, to reassess participants for CUD, identical to the baseline assessments, were
collected.
2.3. Statistical analysis
All analyses were conducted in IBM Statistical Package for Social Sciences (SPSS),
V.21. Assumptions of no perfect multicollinearity (no rs ≥ 0.8), linearity, normally
distributed errors and homoscedasticity were not violated. Correlations were con-
ducted between cannabis dependence, predictors and possible confounders. At
baseline, linear regression was used to assess the predictive relationship of cannabis
variables on cannabis dependence. Tobacco smoking variables were added to the
regression model to establish whether they could explain signiﬁcant additional
variance in CUD. Questionnaire measures that correlated strongly with cannabis
dependence were then added to the model and ﬁnally variables that were not found
to  be signiﬁcant as regression coefﬁcients were removed generating the most par-
simonious model (accounting for the greatest amount of variance with the least
number of variables). Those predictors were then used to predict cannabis depend-
ence in the follow up data. Unstandardised B coefﬁcients are presented with 2
decimal places.
We  used PROCESS for Statistical Package for Social Sciences (SPSS) version
21 (Hayes, 2013; Preacher and Hayes, 2008). Multiple mediation analyses were
conducted on a priori hypotheses. We tested the possible indirect effects of
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AYS-CANNABIS on CANNABIS DEPENDENCE (SDS score) through tobacco smoking
ariables (YEARS-TOB + DAYS-TOB) in a multiple mediator model whist controlling
or  confounding variables in the baseline data. This method parses the relation-
hip between a predictor and an outcome into ‘indirect’ and ‘direct’ effects. Indirect
ffects occur when the predictor inﬂuences the outcome variable through another
ediator variable. Multiple mediators have a combined and a speciﬁc (individ-
al) contribution to the relationship between a predictor and outcome. In contrast,
direct effects’ between the predictor and outcome are statistically independent of
his  mediating relationship. For all analyses we  used bias corrected 95% conﬁdence
ntervals (CI) which resulted from bootstrapping of 10,000 samples. An effect is
eemed signiﬁcant when the B lies within CIs that do not cross zero.
.4. Missing data
For 4 participants, single questionnaire items for the SPQ (5 individual responses
issing in total) were replaced with the mean of the subscale. SPQ data was  missing
or 11 participants. For 8 participants, single questionnaire items for the BIS (10 items
n  total) were replaced with the mean. For the STAI, 7 items in total were replaced
ith the mean. Thus, a total of 0.05% of the baseline data was  replaced with mean
cores.
. Results
.1. Baseline demographics
Participants in this study (N = 298; 71% male) were on average
0.55 ± 1.67 years old with 14.47 ± 1.94 total years in education.
heir mean score on the BDI was 7.27 ± 6.67 with a range of
–40 (normative values; 6.25 ± 4.00 (Crawford et al., 2011)),
4 participants (4.69%) scored >14 (mild depression), STAI
9.41 ± 9.02 (normative values; 36.44 ± 10.93 (Crawford et al.,
011)), BIS 70.73 ± 9.84 (normative values; 64.2 ± 10.70 (Spinella,
007)), WTAR 41.93 ± 6.80, CTQ 37.09 ± 10.04 (normative val-
es; 98.63 ± 29.13 (Paivio and Cramer, 2004)) SPQ (N = 287)
7.67 ± 10.70 (normative values; 26.9 ± 11.00 (Raine, 1991)). 139
46.6%) participants met  criteria for cannabis dependence (score
3 on the SDS) at baseline.
.2. Follow up demographics
The follow up sample (N = 65; 69.2% male) were a mean (SD) age
f 24.66 ± 2.07. 26.2% (N = 17) met  the criteria for cannabis depend-
nce at follow-up (further details of baseline demographics for
his group can be found in Table 3). In comparison to the 233 who
ere not followed up, the 65 who were did not differ signiﬁcantly
n age, gender, primary study variables or smoking characteristics
uggesting that the baseline demographics of the follow up group
re equivalent to the baseline group who were not followed up.
able 1
eans, standard deviations and correlation coefﬁcients of the primary baseline study var
SDS Time to smoke
3.5 g
DAYS-CANNABIS Years cannabis
used
SDS 1.00 −0.19** 0.50*** 0.14* −
Time to smoke 3.5 g 1.00 −0.40*** −0.04 
DAYS-CANNABIS 1.00 0.13* −
Years cannabis
used
1.00 −
Cannabis last used
(days)
DAYS-TOB 
YEARS-TOB 
Tobacco last used
(days)
Cigarettes per day 
M  2.85 8.51 18.50 4.94 
SD  2.73 15.00 10.68 2.34 
* p < .05.
** p < .01.
*** p < .001.ependence 148 (2015) 165–171 167
3.3. Correlations of primary baseline variables (Table 1)
Correlations were conducted between the outcome variable of
SDS score (cannabis dependence), predictors and possible con-
founders (Table 1). SDS correlated positively with scores on the
BDI (r = 0.690, p = 0.003). SDS correlated weakly with the WTAR
(r = −0.16, p = 0.004) and also weakly with scores on the SPQ
(r = 0.133, p = 0.024) but not on the STAI (r = 0.090, p = 0.133) or BIS
(r = 0.090, p = 0.110). BIS scores correlated with cigarettes per day
(r = 0.166, p = 0.004) and days per month cannabis use (r = 0.153,
p = 0.008).
3.4. Regression analysis (Table 2)
3.4.1. Cannabis only model. This model predicted 24.6% of the vari-
ance in cannabis dependence. Cannabis dependence score was
signiﬁcantly predicted by DAYS-CANNABIS. Cannabis dependence
scores increased by 0.12 units for every extra day of cannabis use
per month. Time to smoke an eighth, years of cannabis use and days
since last cannabis use were not predictive of cannabis dependence.
3.4.2. Cannabis + tobacco model. When tobacco variables are added
to regression model, the model predicted 28.5% of the variance in
cannabis dependence (R2 change = 0.038, F change(4,298) = 3.880,
p = 0.004). DAYS-CANNABIS remained a signiﬁcant predictor of
cannabis dependence with dependence scores increasing 0.1
units for every extra day per month. YEARS-TOB was  predic-
tive of cannabis dependence. For every additional year of tobacco
smoking, cannabis dependence scores increased 0.197 units. DAYS-
TOB was a signiﬁcant predictor of cannabis dependence; scores
increased by 0.031 units for every additional day of tobacco use per
month. Time to smoke an eighth, years cannabis smoked and days
since last cannabis use were not predictive of cannabis dependence.
3.4.3. Cannabis, tobacco + confounders model. Variables that corre-
lated strongly with cannabis dependence scores were added to
the regression model. BDI score signiﬁcantly predicted cannabis
dependence. For every unit increase on the BDI, cannabis
dependence scores increased by 0.046 units. As such the model
predicted 30.4% of the variance in cannabis dependence scores (R2
change = 0.019, F change(2,287) = 3.955, p = 0.020).
iables.
Cannabis last
used (days)
DAYS-TOB YEARS-TOB Tobacco last
used (days)
Cigarettes per
day
0.25*** 0.30*** 0.26*** 0.00 0.20**
0.18** −0.11 0.00 0.01 −0.08
0.46*** 0.33*** 0.18** 0.01 0.24***
0.17** 0.13* 0.59*** 0.09 0.16**
1.00 −0.16 −0.07 −0.02 −0.10
1.00 0.24*** −0.18** 0.44***
1.00 −0.09 0.19**
1.00 −0.09
1.00
3.76 23.61 4.70 20.10 7.17
6.05 10.01 2.53 111.85 5.86
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Table 2
Predicting cannabis dependence from cannabis exposure variables only, tobacco
exposure variables, and psychological correlates (confounders) to develop the most
efﬁcient model.
B BCa
95% CI (lower,
upper)
p
Cannabis only
R2 = 0.246, p < 0.001
Constant 0.221 −0.65, 1.11 0.632
Time to smoke 3.5 g 0.001 −0.02, 0.23 0.929
DAYS-CANNABIS 0.120 0.09, 0.15 <0.001
years cannabis used 0.090 −0.03, 0.21 0.144
cannabis last used −0.012 −0.06, 0.03 0.537
Cannabis + tobacco
R2 = 0.285, F = 23.93, p < 0.001
Constant −0.400 −1.34, 0.51 0.415
Time to smoke 3.5 g −0.002 −0.02, 0.18 0.866
DAYS-CANNABIS 0.101 0.07, 0.13 <0.001
Years cannabis used −0.054 −0.18, 0.09 0.407
Cannabis last used −0.020 −0.07, 0.03 0.321
DAYS-TOB 0.031 0.00, 0.06 0.020
YEARS-TOB 0.197 0.06, 0.32 0.003
Tobacco last used 0.001 0.00, 0.03 0.174
Cigarettes per day 0.010 −0.04, 0.07 0.728
Cannabis, tobacco + confounders
R2 = 0.304, F = 12.52, p < 0.001
Constant 0.560 −1.30, 2.30 0.552
Time to smoke 3.5 g −0.001 −0.02, 0.02 0.934
DAYS-CANNABIS 0.098 0.07, 0.13 <0.001
Years cannabis used −0.022 −0.15, 0.11 0.766
Cannabis last used −0.023 −0.07, 0.03 0.363
DAYS-TOB 0.030 0.00, 0.06 0.057
YEARS-TOB 0.175 0.04, 0.31 0.012
Tobacco last used 0.001 −0.05, 0.05 0.488
Cigarettes per day 0.010 −0.07, 0.01 0.984
WTAR −0.029 0.01, 0.40 0.160
BDI  −0.046 0.00, 0.09 0.033
Most efﬁcient model
R2 = 0.295, F = 30.72, p < 0.001
Constant −0.933 −1.62, −0.28 0.008
DAYS-CANNABIS 0.107 0.08, 0.13 <0.001
DAYS-TOB 0.029 0.01, 0.05 0.010
3
t
w
+
c
D
c
As a result of DAYS-TOB and YEARS-TOB being signiﬁcant pre-
T
MYEARS-TOB 0.159 0.05, 0.27 0.006
BDI  0.050 0.01, 0.10 0.020
.5. Most efﬁcient model
When redundant predictors were removed from the analysis,
he model predicated 29.5% of the variance in cannabis dependence,
hich is not signiﬁcantly different from model 3 (cannabis, tobacco
 confounders) which includes cannabis, tobacco and potential
onfounders (R2 change = 0.090, F change(4,293) = 0.008, p = 0.750).
AYS-CANNABIS remained the most important predictor of
annabis dependence, followed by YEARS-TOB, DAYS-TOB and BDI
able 3
eans, standard deviations and correlation coefﬁcients of the primary baseline study var
Baseline 
SDS DAYS-CANNABIS D
Baseline
SDS 1.00 0.57*** 0
DAYS-CANNABIS 1.00 0
DAYS-TOB 1
YEARS-TOB 
BDI  
Follow-up SDS 
M  2.80 19.25 23
SD  2.64 10.63 9
* p < .05.
** p < .01.
*** p < .001.ependence 148 (2015) 165–171
score. In this model, r = 0.54 for the most efﬁcient model which is
considered a large effect size (Cohen, 1988).
3.6. Exploratory regression analysis
Demographic variables were added to the most efﬁcient given
the associations between these variables and CUD (as sex dif-
ferences have been reported in relation to abuse related effects;
Cooper and Haney, 2014). When gender is added to this model, the
model predicts 29.6% of the variance in cannabis dependence (R2
change = 0.010, F change(1,292) = 0.180, p = 0.670).
Age was then added to the most efﬁcient model (without gen-
der). This model accounts for 30.7% of the variance in cannabis
dependence (R2 change = 0.011, F change(1,292) = 4.740, p = 0.030).
The addition of Age (B = 0.198, 95% BCI = 0.037, 0.368) correlated
highly with the variable YEARS-TOB, which was no longer signiﬁ-
cant when age was  added (B = 0.096, 95% BCI = −0.035, −0.223).
Finally, scores on the CTQ were added to the regression model.
This model accounted for 28.7% in the variance of cannabis depend-
ence (R2 change = 0.001, F change(1,278) = 0.440, p = 0.510).
3.7. Exploratory follow-up analysis
3.7.1. Regression at follow-up (Table 4).
3.7.1.1. Most efﬁcient model. The signiﬁcant predictors in the base-
line regression (Table 2) were used to predict cannabis dependence
at follow-up, 4 years later. This was to gage whether the same fac-
tors that predict dependence at baseline can predict dependence at
follow up. Means, standard deviations and correlation coefﬁcients
of these variables can be found in Table 3. This model predicted
18.5% of the variance in dependence at follow-up. DAYS-CANNABIS,
DAYS-TOB and YEARS-TOB and BDI score were not signiﬁcant pre-
dictors of cannabis dependence at follow up.
3.7.2. Most efﬁcient model accounting for baseline cannabis depend-
ence. Baseline cannabis dependence was  added to the model stated
above. As a result, cannabis dependence became the only signiﬁ-
cant predictor of predicted cannabis dependence at follow-up (R2
change = 0.062, p < 0.031). This model predicted 24.8% of the vari-
ance in dependence at follow-up.
3.8. Multiple mediation analysis (Fig. 2)dictors of baseline cannabis dependence in the linear regression
(Table 2), these variables were used a mediators in a multiple
mediator model to discern if the relationship between cannabis
iables with follow up cannabis dependence (n = 65).
Follow up
AYS-TOB YEARS-TOB BDI SDS
.42** 0.29* 0.12 0.37**
.39** 0.29* 0.14 0.26*
.00 0.31* 0.14 0.23
1.00 −0.07 0.09
1.00 0.37**
1.00
.53 5.25 6.51 1.40
.93 2.31 5.59 2.29
C. Hindocha et al. / Drug and Alcohol D
Table  4
Predicting cannabis dependence at follow up from variables that predicted baseline
cannabis dependence i.e. the most efﬁcient model and assessing whether they still
account for the model when cannabis dependence at baseline is added as a factor.
B BCa
95% CI (lower,
upper)
p
Most efﬁcient model
R2 = 0.139, F = 1.85, p < 0.135
Constant −0.708 −2.25, 0.59 0.409
DAYS-CANNABIS 0.039 −0.03, 0.10 0.164
DAYS-TOB 0.010 −0.04, −0.06 0.748
YEARS-TOB 0.042 −0.19, 0.28 0.741
BDI  0.137 −0.44, 0.32 0.265
Most efﬁcient model accounting for baseline dependence
R2 = 0.266, F = 3.264, p < 0.013
Constant −0.361 −1.88, 0.94 0.668
DAYS-CANNABIS 0.008 −0.06, 0.07 0.770
DAYS-TOB −0.006 −0.51, 0.04 0.852
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aYEARS-TOB 0.014 −0.21, 0.25 0.910
BDI  0.138 −0.05, 0.32 0.294
Baseline SDS 0.274 0.05, 0.53 0.023
se (DAYS-CANNABIS) and cannabis dependence (SDS score) was
ediated by concurrent tobacco use.
A bias-corrected and accelerated bootstrapped multiple medi-
tion model conﬁrmed the presence of a combined indirect
ffect of DAYS-CANNABIS on cannabis dependence through
EARS-TOB + DAYS-TOB (B = 0.017, 95% CI = 0.008, 0.288), with sig-
iﬁcant, speciﬁc indirect effects through YEARS-TOB (B = 0.007 95%
I = 0.002, 0.016) and DAYS-TOB (B = 0.010, 95% CI = 0.003, 0.020)
product of paths a and b in Fig. 2). This model accounted for
8% of the variance in cannabis dependence, whereas the direct
ffect of DAYS-CANNABIS on CANNABIS DEPENDENCE, accounted
or 23% (direct B = 0.108, 95% CI = 0.008, −0.028). Pairwise compari-
on between speciﬁc indirect effects was not signiﬁcant (B = −0.003,
5% CI = −0.014, 0.008) suggesting that both YEARS-TOB and DAYS-
OB are not statistically different from each other i.e. have equal
mportance in mediating this relationship. The direct route (c and
′) suggests that when taking into account the mediating role of
obacco smoking, DAYS-CANNABIS is still signiﬁcant.
.9. Inﬂuence of confounds
Given that both BDI and WTAR correlated with dependence
t baseline, these were added as covariates into the above anal-
sis. As such this model predicted 30% of the variance in cannabis
ependence. The indirect effect of DAYS-CANNABIS on CANNABIS
EPENDENCE through YEARS-TOB and DAYS-TOB whilst control-
ing for BDI and WTAR was signiﬁcant (B = 0.015, 95% CI = 0.007,
.027) with speciﬁc indirect effects through YEARS-TOB (B = 0.007,
5% CI = 0.002, 0.015), and DAYS-TOB (B = 0.009, 95% CI = 0.003,
.018), with no signiﬁcant difference between DAYS-TOB and
EARS-TOB. The direct effect of DAYS-CANNABIS on CANNABIS
ig. 2. Multiple mediator model. Paths a, b, c and c′ are OLS regression coefﬁcients in unst
re  included as mediators. Path c represents the effect of x on y when the tobacco variablependence 148 (2015) 165–171 169
DEPENDENCE when controlling for these covariates is still signiﬁ-
cant (B = 0.105, 95% CI = 0.078, 0.131).
4. Discussion
The main aim of this study was  to investigate the role of cigarette
smoking on cannabis dependence, above and beyond the effects of
cannabis exposure, in a sample of young cannabis and tobacco co-
users. We conducted an exploratory follow-up of these users four
years later with a 27% response rate of which 70% of individuals
had smoked cannabis and tobacco at baseline. The 65 participants
that were followed up were equivalent in demographics and smok-
ing behaviour to those who  were not followed up, at baseline. We
hypothesised that cigarette smoking would predict CUD, at both
time points. We  also investigated whether the effects of cannabis
use on cannabis dependence were mediated by cigarette smoking.
Cigarette smoking at baseline was predictive of CUD at baseline
when controlling for cannabis use variables in young people who
smoke cannabis and tobacco. The most efﬁcient model accounted
for 30% of the variance in cannabis dependence which is consid-
ered to be a large effect size as R > 0.5 (Cohen, 1988). However,
this seems no longer the case four years later, where only base-
line CUD predicted follow-up CUD, accounting for almost 25% of
the variance and replicating previous ﬁndings (Swift et al., 2000).
When we investigated how cigarette smoking predicted concurrent
CUD; we  found that cigarette smoking (years of cigarette smoking
and days per month cigarette smoking) mediated the relationship
between cannabis use and cannabis dependence suggesting a role
of tobacco use in the pathogenesis of CUD in cannabis and tobacco
users. We  also found these effects to be robust when controlling
for depression and premorbid IQ (which were found to be compa-
rable to normative values). Although causality cannot be assumed
in this cross-sectional analysis, these results suggest that cigarette
smoking may  enhance the dependence-forming effects of cannabis.
Alternatively, our results may  suggest that CUD  (as measured by the
SDS) may  capture some aspects of nicotine dependence in a subset
of young people with CUD. As such, this research supplements pre-
vious epidemiological research that stresses the predictive ability
of tobacco smoking in developing CUDs (Coffey et al., 2000; Prince
van Leeuwen et al., 2014; von Sydow et al., 2002).
Our results, based in a naturalistic setting, parallel results from
a recent controlled lab study that found cannabis users who smoke
cigarettes are more likely to relapse in comparison to those who
do not smoke cigarettes, perhaps as a result of this indirect path-
way (de Dios et al., 2009; Haney et al., 2012). As such, reducing
cannabis dependence might be facilitated by helping individuals
quit cigarette smoking (Macleod et al., 2004). We were able to
account for about 30% of the variance in CUD  from four predictor
variables. However, CUD is a complex disorder and causality cannot
be determined from one factor. There are many other factors that
can predict CUD that were beyond the scope of the current study
andardised form. Path c′ represents the effect of x on y when tobacco variables (m)
es are not included as mediators. *p < .05, **p < .01, ***p < .001.
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ut have interesting implications. For example, a recent study by
an der Pol et al. (2013) found that current problems (such as liv-
ng alone, coping motives for cannabis use and negative life events)
ere better predictors of cannabis dependence in young adults
han cannabis exposure itself. As a result of this study, we included
emographics and scores on the CTQ to our most efﬁcient model,
owever these did not account for a signiﬁcant proportion of vari-
nce to be included in the ﬁnal model or in the mediation analysis.
t is clear that CUD is a complex disorder that has many predictors
nd vulnerability factors that were not included in the model.
In the past, regular cigarette smoking would precede cannabis
se (Kandel et al., 1992). This sequence in drug use seems to be
apering off, for example, around 1 in 5 young cannabis users have
ever smoked a cigarette (Suris et al., 2007). Interestingly, both
annabis and tobacco smoking were initiated 4.9 and 4.7 years pre-
iously, respectively, at the baseline visit, suggesting simultaneous
ge of onset in the current study. Therefore, these results do not
peak to sequential use as on average the sample initiated both
ubstances at the same time.
Stricter tobacco laws in some countries have altered perceptions
uch that cigarette smoking is considered a more risky behaviour
han previously. In 2013, for the ﬁrst time, tobacco smoking preva-
ence was estimated to be below 20% in the UK (Brown and West,
014). In comparison, cannabis use has become normal and per-
eptions of regular cannabis use as a risky behaviour are at an
ll-time low (Johnston et al., 2013) with risk perception inversely
elated to prevalence of cannabis use (Kleber and Dupont, 2012).
his may  be due to the shifting landscape and debate over legali-
ation of both medical and recreational marijuana in states such as
olorado, California and Washington in the United States as well
s countries such as Uruguay and the Netherlands (Volkow et al.,
014). As a result, whilst tobacco smoking decreases generally, it
s possible that tobacco use will also increase indirectly over time
ue to increased cannabis use (Patton et al., 2005). Our ﬁndings
re timely because they suggest tobacco may  be involved in the
athogenesis of CUD, a possible risk factor of legalisation.
Our results may  be a product of the common liability to the use of
annabis and tobacco including such risk factors like shared genetic
nd temperamental factors (Agrawal et al., 2008, 2010; Brook et al.,
010; Creemers et al., 2009). For example, recent research shows
hat nicotine dependence was associated stronger with lifetime
UD for females than males (Blanco et al., 2014). Moreover, Cooper
nd Haney (2014) have recently demonstrated that whilst subjec-
ive effects are equal across genders, females report more abuse
elated effects. Thus, an interesting analysis would be to investi-
ate whether the mediators suggested in the present study, were
tronger in females than males however, given that the sample
as 71% male, this was not possible. Demographic variables were
nstead added to the most efﬁcient model and we found that gen-
er and age did not predict cannabis dependence after accounting
or cannabis and tobacco use. Our results may  also be a product of
he common route of administration (Agrawal and Lynskey, 2009)
here inhalation of one substance may  sensitise an individual to
he inhalation of another substance.
.1. Strengths and limitations
This study has several strengths including a relatively large
ample size of 298 young cannabis and tobacco users assessed in
heir own homes. Moreover, we used continuous variables to index
oth cannabis and tobacco smoking making it possible to assess
he relationship between drug use variables at varying levels of
everity (Ramo et al., 2013). This study also suffers from several
imitations. First, within our exploratory follow-up sample we had
 modest response from 65 participants. This may  have reduced
he power to detect a possible true effect of baseline cannabis useependence 148 (2015) 165–171
on future dependence (for example, surprisingly, days of cannabis
use per month at baseline were not associated with cannabis
dependence at follow up) and therefore these exploratory follow-
up results should be interpreted with caution until they can be
replicated with a greater sample size. Moreover, we  were unable to
control for the simultaneous use of cannabis and tobacco (joints)
as the route of administration and as a necessity our sample is
limited those who only smoke cannabis and tobacco. These results
should be interpreted within their self-reported context. Finally,
the multiple mediation analysis was conducted on cross sectional
data and therefore the existence and direction of causality cannot
be discerned.
4.2. Conclusions
In light of the medicalisation and legalisation of marijuana,
research on cannabis and tobacco use is essential. In a natural-
istic study of cannabis and tobacco co-users, baseline cigarette
smoking (frequency and years) predicts cannabis dependence con-
currently when controlling for frequency of cannabis use; however
this was no longer the case four years later. At baseline, cigarette
smoking mediated the relationship between cannabis use and
cannabis dependence, even when controlling for psychological
and demographic correlates that might explain this relationship.
This suggests that cigarette smoking enhances vulnerability to the
harmful effects of cannabis.
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